Prospective Multicentric Randomized Phase III Study of Imatinib in Patients with Advanced Gastrointestinal Stromal Tumors Comparing Interruption Versus Continuation of Treatment Beyond 1 Year: The French Sarcoma Group - Blay, J Y; Le Cesne, A; Ray-Coquard, I (J Clin Oncol, 2007)